Frontlight ResearchEarly access
Neuromyelitis optica (NMOSD) trials in South Korea
2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleRegistry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
- Where
- Daejeon, Gyeonggi-do, Seoul
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT05966467 - No phaseActive, not recruitingStudy of Ultomiris® (Ravulizumab) Safety in Pregnancy
- Where
- Seoul
- People
- 75 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644